Hodgkin's Disease Drug Passes Early Clinical Trial
Thursday, November 4, 2010 - 14:20
in Health & Medicine
A drug that combines a cell-killing agent with an antibody may result in remission for some patients with Hodgkin's disease and other blood cancers